Humana reported $137.2B of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $137.2B (to Q1 2026). Net Income: $1.13B, trailing twelve months to Q1 2026. Free Cash Flow: $1.27B, trailing twelve months to Q1 2026. Op Margin: 1.6%, trailing twelve months to Q1 2026.

HUMHumana

HealthcareUSD

$391.02

$162.8452 weeks$407.90

HUM as reported

Humana reported $137.2B of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed.

$137.2B

Revenue, trailing twelve months · to Q1 2026 · +14% against the twelve months before

Net Income: $1.13B
Net Income · −34% year on year · trailing twelve months to Q1 2026
Free Cash Flow: $1.27B
Free Cash Flow · −47% year on year · trailing twelve months to Q1 2026
Op Margin: 1.6%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for HUM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$137.2B	+14%	Q1 2026
Net Income	$1.13B	−34%	Q1 2026
EPS	$9.37	−34%	Q1 2026
Op Margin	1.6%	n/a	Q1 2026
Net Margin	0.71%	n/a	Q1 2026
ROE	7.1%	n/a	Q1 2026
ROA	2.5%	n/a	Q1 2026
ROIC	23%	n/a	Q1 2026
Free Cash Flow	$1.27B	−47%	Q1 2026
P/E	41.7	n/a	today